[Pharmacologic correction of psycho-emotive disorders in the rehabilitation of patients after removal of brain tumors].
Koval'chuk
V V
VV
D000328:Adult; D000525:Alprazolam / Q000627:therapeutic use; D000639:Amitriptyline / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy / Q000209:etiology; D001932:Brain Neoplasms / Q000601:surgery*; D003863:Depression / Q000188:drug therapy / Q000209:etiology; D004316:Doxepin / Q000627:therapeutic use; D004644:Emotions; D005260:Female; D006801:Humans; D008297:Male; D008376:Maprotiline / Q000627:therapeutic use; D008875:Middle Aged; D020912:Moclobemide / Q000627:therapeutic use; D019964:Mood Disorders / Q000188:drug therapy* / Q000209:etiology*; D019635:Neurosurgical Procedures / Q000009:adverse effects*; D009526:Nialamide / Q000627:therapeutic use; D020280:Sertraline / Q000627:therapeutic use; D013841:Thiazepines / Q000627:therapeutic use; D014196:Trazodone / Q000627:therapeutic use; D016896:Treatment Outcome
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D013841:Thiazepines; C050504:tianeptine; D004316:Doxepin; D000639:Amitriptyline; D008376:Maprotiline; D020912:Moclobemide; D020280:Sertraline; D009526:Nialamide; D014196:Trazodone; D000525:Alprazolam